Staphylococcus aureus Capsular Polysaccharide Types 5 and 8 Reduce Killing by Bovine Neutrophils In Vitro
Open Access
- 1 March 2005
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (3) , 1578-1583
Abstract
Isogenic variants of Staphylococcus aureus strain Reynolds expressing either no capsule or capsular polysaccharide (CP) type 5 (CP5) or type 8 (CP8) were used to assess the effect of CP on bacterial killing and the respiratory burst of bovine neutrophils. The effects of antisera specific for CP5 and CP8 were also evaluated. The killing of live bacteria by isolated neutrophils was quantified in a bactericidal assay, while the respiratory burst after stimulation with live bacteria in whole blood was measured by flow cytometry. The expression of a CP5 or CP8 capsule protected the bacteria from being killed by bovine neutrophils in vitro (P < 0.001), and the capsule-expressing variants did not stimulate respiratory burst activity in calf whole blood. The addition of serotype-specific antisera increased the killing of the capsule-expressing bacteria and enhanced their stimulating effect in the respiratory burst assay (P < 0.01). When the S. aureus variants were grown under conditions known not to promote capsule expression, there were no significant differences between them. The present study demonstrates that the expression of S. aureus CP5 or CP8 confers resistance to opsonophagocytic killing and prevents the bacteria from inducing respiratory burst of bovine neutrophils in vitro and that these effects can be reversed by the addition of serotype-specific antisera.Keywords
This publication has 40 references indexed in Scilit:
- Staphylococcus aureusCapsular PolysaccharidesClinical Microbiology Reviews, 2004
- Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 2002
- The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genesMicrobiology, 1997
- Field trial of a staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessmentsAustralian Veterinary Journal, 1996
- Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide—ovalbumin conjugateVaccine, 1994
- Production of type 5 capsular polysaccharide by Staphylococcus aureus grown in a semi-synthetic mediumJournal of General Microbiology, 1991
- A colorimetric assay for quantitating bovine neutrophil bactericidal activityVeterinary Immunology and Immunopathology, 1991
- Induction of Anti‐Phagocytic Surface Properties of Staphylococcus aureus from Bovine Mastitis by Growth in Milk WheyJournal of Veterinary Medicine, Series B, 1991
- Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureusDiagnostic Microbiology and Infectious Disease, 1984
- CAPSULE PRODUCTION AND VIRULENCE AMONG STRAINS OF STAPHYLOCOCCUS AUREUSAnnals of the New York Academy of Sciences, 1974